SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-211932
Filing Date
2020-08-06
Accepted
2020-08-06 16:21:33
Documents
14
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d159109d8k.htm   iXBRL 8-K 25594
2 EX-99.1 d159109dex991.htm EX-99.1 68634
6 GRAPHIC g159109dsp001.jpg GRAPHIC 6959
  Complete submission text file 0001193125-20-211932.txt   234789

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xoma-20200806.xsd EX-101.SCH 3057
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20200806_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20200806_pre.xml EX-101.PRE 11399
7 EXTRACTED XBRL INSTANCE DOCUMENT d159109d8k_htm.xml XML 3449
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14710 | Film No.: 201082026
SIC: 2834 Pharmaceutical Preparations